Markets.com Logo
markets.com

EXAS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    46.9762$
  • Previous Close
    46.7671$
  • 52 Week Change
    34.02$
  • Day Range
    0.21$
  • 52 Week High/Low
    38.8118$ - 72.83$
  • Dividend Per Share
    --
  • Market cap
    8 837 M$
  • EPS
    -0.01
  • Beta
    0.928
  • Volume
    --

About

EXAS.US represents the common stock of Exact Sciences Corporation traded on the Nasdaq Stock Market in the United States. Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. Their primary product is Cologuard, a non-invasive, stool-based DNA screening test used to detect early signs of colorectal cancer and advanced adenomas. Investors can track the performance of Exact Sciences through the EXAS.US ticker symbol, monitoring factors such as revenue growth, earnings reports, and the adoption rate of Cologuard to assess the company's potential and make investment decisions.
markets.com
Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Julian Parker|--
Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Julian Parker|--
Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Julian Parker|--
Cryptos shine again, USD on the edge

Cryptos shine again, USD on the edge

Darius Anucauskas|--
Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Julian Parker|--
Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Julian Parker|--
Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Daniel Carter|--

Factors

Ensure that there is a double line break between each factor. Cancer Screening Demand: Increased demand for Exact Sciences' Cologuard and other cancer screening tests generally drives the stock price higher. Competition: The emergence of competing cancer screening technologies and products can negatively impact EXAS.US's market share and stock price. Clinical Trial Results: Positive results from clinical trials evaluating the effectiveness or expanding the use of Exact Sciences' tests can boost investor confidence. Reimbursement Policies: Changes in insurance coverage and reimbursement rates for Exact Sciences' tests by government and private payers significantly affect revenue. Economic Conditions: Overall economic downturns can impact healthcare spending, potentially affecting demand for preventive screening tests. Regulatory Changes: New regulations or changes to existing ones related to cancer screening and diagnostics can influence the company's operations and stock performance.

People Also Watch

Latest news

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

Julian Parker|--
Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Julian Parker|--
SK Hynix Stock Drops 5% as Workers Reject Pay Deal

SK Hynix Stock Drops 5% as Workers Reject Pay Deal

Julian Parker|--

Latest Education Articles

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

Daniel Carter|--
How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

Daniel Carter|--
How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

Daniel Carter|--
Recommended Topics
markets.com